Cancer Family
Embryonal Neoplasm
CI-CAN-00000013Explore in graph →
Non-malignant285 active trials7 approved drugs73 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000013Explore in graph →
Clinical trials
1,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00947167 | A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors | terminated | Phase 2 | 4 | Pamela L. KunzOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00582608 | Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9 | terminated | N/A | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 1, 2017 | clinicaltrials |
| NCT00150072 |
| Efficacy and Safety of Imatinib in Chordoma |
| completed |
| Phase 2 |
| 55 |
| Novartis PharmaceuticalsINDUSTRY |
| 2 |
| Feb 23, 2017 |
| clinicaltrials |
| NCT00445718 | Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging | completed | — | 97 | Children's Oncology GroupNETWORK | 3 | Feb 9, 2017 | clinicaltrials |
| NCT00726934 | The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients | completed | N/A | 149 | Indiana UniversityOTHER | 1 | Feb 8, 2017 | clinicaltrials |
| NCT03042429 | Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients(NB2004-HR) | completed | Phase 3 | 360 | University of CologneOTHER | 1 | Feb 6, 2017 | clinicaltrials |
| NCT00713037 | Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas | completed | N/A | 20 | Massachusetts General HospitalOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT00946283 | Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome | terminated | N/A | 30 | Rutgers, The State University of New JerseyOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT01204450 | Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma | terminated | Phase 1 | 7 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Dec 23, 2016 | clinicaltrials |
| NCT00563680 | QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors | completed | Phase 2 | 38 | NantCell, Inc.INDUSTRY | 0 | Oct 27, 2016 | clinicaltrials |
| NCT00793351 | Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation | completed | Phase 2 | 25 | Samsung Medical CenterOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT01808079 | Gene Analysis in Studying Susceptibility to Wilms Tumor | completed | — | 1 | Children's Oncology GroupNETWORK | 1 | Aug 22, 2016 | clinicaltrials |
| NCT02681705 | Radiation Therapy and Combination Chemotherapy for Medulloblastoma | unknown | Phase 2 | 60 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Aug 17, 2016 | clinicaltrials |
| NCT00960739 | Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma(MIITOP) | completed | Phase 2 | 30 | Centre Oscar LambretOTHER | 1 | Aug 8, 2016 | clinicaltrials |
| NCT02457650 | T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies | unknown | Phase 1 | 36 | Shenzhen Second People's HospitalOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT01876303 | Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma | completed | — | 1,650 | Children's Oncology GroupNETWORK | 1 | Jul 14, 2016 | clinicaltrials |
| NCT01353300 | Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer | completed | — | 31 | Children's Oncology GroupNETWORK | 0 | Jul 11, 2016 | clinicaltrials |
| NCT01493830 | Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma | completed | — | 5 | Children's Oncology GroupNETWORK | 0 | Jul 11, 2016 | clinicaltrials |
| NCT00670410 | Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma | terminated | Phase 1 | 15 | Columbia UniversityOTHER | 1 | Jun 24, 2016 | clinicaltrials |
| NCT00049023 | Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors | completed | Phase 1 | 27 | O'Dorisio, M SOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT01048086 | 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET) | withdrawn | Phase 2 | 0 | University of IowaOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT02615106 | Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma | unknown | Phase 2 | 60 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jun 14, 2016 | clinicaltrials |
| NCT02771743 | Response-based Treatment of High-risk Neuroblastoma | unknown | Phase 2 | 54 | Samsung Medical CenterOTHER | 1 | May 24, 2016 | clinicaltrials |
| NCT00897637 | Gene Expression Profiles to Categorize Wilms Tumors | completed | — | 600 | Children's Oncology GroupNETWORK | 1 | May 19, 2016 | clinicaltrials |
| NCT01118078 | Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor | completed | — | 185 | Children's Oncology GroupNETWORK | 1 | May 19, 2016 | clinicaltrials |
| NCT01493817 | Biomarkers in Samples From Younger Patients With Wilms Tumor | completed | — | 30 | Children's Oncology GroupNETWORK | 1 | May 19, 2016 | clinicaltrials |
| NCT01510600 | Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma | completed | — | 99 | Children's Oncology GroupNETWORK | 0 | May 19, 2016 | clinicaltrials |
| NCT00898391 | Study of DNA in Blood Samples From Patients With Neuroblastoma | completed | — | 329 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT01169376 | Biomarkers in Young Patients With Neuroblastoma | completed | — | 380 | Children's Oncology GroupNETWORK | 0 | May 18, 2016 | clinicaltrials |
| NCT01336881 | Biomarkers in Tissue Samples From Young Patients With Liver Cancer | completed | — | 99 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT01387724 | Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma | completed | — | 300 | Children's Oncology GroupNETWORK | 0 | May 18, 2016 | clinicaltrials |
| NCT01553448 | Studying Gene Expression in Samples From Younger Patients With Neuroblastoma | completed | — | 75 | Children's Oncology GroupNETWORK | 0 | May 18, 2016 | clinicaltrials |
| NCT01585649 | PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma | completed | Phase 1 | 21 | Merckle GmbHINDUSTRY | 6 | May 18, 2016 | clinicaltrials |
| NCT01589341 | Studying Chromosomes in Samples From Younger Patients With Neuroblastoma | completed | — | 300 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT00898053 | Study of Tumor Samples From Patients With Ewing Sarcoma | completed | — | 200 | Children's Oncology GroupNETWORK | 1 | May 17, 2016 | clinicaltrials |
| NCT01407731 | Protein Expression in Human Neuroblastoma Tumor Samples | completed | — | 20 | Children's Oncology GroupNETWORK | 0 | May 17, 2016 | clinicaltrials |
| NCT01520233 | Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma | completed | — | 100 | Children's Oncology GroupNETWORK | 0 | May 17, 2016 | clinicaltrials |
| NCT01567046 | Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas | completed | — | 70 | Children's Oncology GroupNETWORK | 1 | May 17, 2016 | clinicaltrials |
| NCT00824083 | Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment | completed | — | 950 | University Hospital MuensterOTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT01358604 | Biomarkers in Samples From Young Patients With Neuroblastoma | completed | — | 20 | Children's Oncology GroupNETWORK | 0 | Apr 15, 2016 | clinicaltrials |
| NCT02714790 | Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia(LAM-MMR) | completed | — | 281 | A.O.U. Città della Salute e della ScienzaOTHER | 0 | Mar 23, 2016 | clinicaltrials |
| NCT00293384 | Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant | completed | N/A | 40 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 15, 2016 | clinicaltrials |
| NCT00326664 | AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors | completed | Phase 1 | 55 | National Cancer Institute (NCI)NIH | 1 | Mar 7, 2016 | clinicaltrials |
| NCT01440283 | A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma | terminated | Phase 2 | 14 | St. Jude Children's Research HospitalOTHER | 1 | Mar 3, 2016 | clinicaltrials |
| NCT00939484 | Vismodegib in Treating Patients With Recurrent or Refractory Medulloblastoma | completed | Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Feb 25, 2016 | clinicaltrials |
| NCT02444884 | MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors | completed | Phase 1 | 54 | Children's Oncology GroupNETWORK | 0 | Feb 9, 2016 | clinicaltrials |
| NCT01169584 | Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients | completed | Phase 1 | 6 | Jennerex BiotherapeuticsINDUSTRY | 1 | Jan 21, 2016 | clinicaltrials |
| NCT01239316 | Vismodegib in Treating Younger Patients With Recurrent or Refractory Medulloblastoma | completed | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2016 | clinicaltrials |
| NCT01734863 | Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients | withdrawn | Phase 3 | 0 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Jan 12, 2016 | clinicaltrials |
| NCT00080873 | Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation | completed | N/A | 195 | Children's Oncology GroupNETWORK | 4 | Jan 7, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Mar 3, 2017source: clinicaltrials